| Title | Directed therapy for exfoliation syndrome. | | Author(s) | Angelilli A, Ritch R | | Institution | Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, NY, USA. | | Source | Open Ophthalmol J 2009.:70-4. | | Abstract | Exfoliation syndrome (XFS) is an age-related disorder of the extracellular matrix that leads the production of abnormal fibrillar material that leads to elevated intraocular pressure and a relatively severe glaucoma. Exfoliation material is deposited in numerous ocular tissues and extraocular organs. XFS is associated with ocular ischemia, cerebrovascular disease, neurodegenerative disease and cardiovascular disease. Current modalities of treatment include intraocular pressure lowering with topical antihypertensives, laser trabeculoplasty and filtration surgery. The disease paradigm for XFS should be expanded to include directed therapy designed specifically to target the underlying disease process. Potential targets include preventing the formation or promoting the depolymerization of exfoliation material. Novel therapies targeting trabecular meshwork may prove particularly useful in the care of exfoliative glaucoma. The systemic and ocular associations of XFS underscore the need for a comprehensive search for neuroprotective agents in its treatment. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19888433 |
|
